Background: Aluminum phosphide (AlP) is a highly toxic poison which directly affects cardiovascular system and results in death. Thus, this study was performed with the aim to evaluate the effect of venoarterial extracorporeal membrane oxygenation (VA-ECMO) on treatment outcomes in these patients.